AnteoTech Advances Battery and Diagnostics Deals, Ends Quarter With $11 Million Cash
ADO: $0.016 +14.29% · MC: $56M
AnteoTech reported expanded customer evaluations and commercial activity across its battery and life sciences businesses, including agreements with Xerabrid and Airspeeder and progress on a collaboration with a global life sciences company. It received approximately $2 million in research and development tax incentives and ended the quarter with $11 million in cash and cash equivalents, including $5.5 million on term deposit, with no bank debt. The excerpt does not provide a prior-quarter cash figure for comparison.

Comments